Cargando…
Critically short telomeres and toxicity of chemotherapy in early breast cancer
Cumulative toxicity from weekly paclitaxel (myalgia, peripheral neuropathy, fatigue) compromises long-term administration. Preclinical data suggest that the burden of critically short telomeres (< 3 kilobases, CSTs), but not average telomere length by itself, accounts for limited tissue renewal a...
Autores principales: | Quintela-Fandino, Miguel, Soberon, Nora, Lluch, Ana, Manso, Luis, Calvo, Isabel, Cortes, Javier, Moreno-Antón, Fernando, Gil-Gil, Miguel, Martinez-Jánez, Noelia, Gonzalez-Martin, Antonio, Adrover, Encarna, de Andres, Raquel, Viñas, Gemma, Llombart-Cussac, Antonio, Alba, Emilio, Mouron, Silvana, Guerra, Juan, Bermejo, Begoña, Zamora, Esther, García-Saenz, Jose Angel, Simon, Sonia Pernas, Carrasco, Eva, Escudero, María José, Campo, Ruth, Colomer, Ramón, Blasco, Maria A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400599/ https://www.ncbi.nlm.nih.gov/pubmed/28423524 http://dx.doi.org/10.18632/oncotarget.15592 |
Ejemplares similares
-
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021) -
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
por: Bueno, Maria J, et al.
Publicado: (2017) -
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021) -
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
por: Quintela-Fandino, Miguel, et al.
Publicado: (2019) -
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
por: Jimeno, Rebeca, et al.
Publicado: (2022)